Monocular viewing or pathological visual field defects reveal the blind-spot effect

What it is

The other entries in this group cover why the blind spot exists, why it goes unnoticed under binocular viewing, and how the brain actively fills it in even under monocular viewing. This entry covers the specific condition that disables this "goes unnoticed" protection: once viewing becomes monocular (the other eye covered, closed, or itself blind or severely impaired), the binocular-compensation safeguard is gone, leaving only perceptual filling-in to hold the fort by itself — and filling-in has its own limits (it degrades when the surrounding background isn't uniform or regular enough). Once conditions exceed what filling-in can cover, the blind-spot effect surfaces in some form — it might be a genuine miss of information, or a vague sense that "something seems off in that area" without being able to say what.

Beyond exposing the physiological blind spot, this entry also covers a more serious category: pathological scotomas caused by retinal disease or optic neuropathy (glaucoma, retinal detachment, macular degeneration). These visual field defects vary in position, size, and boundary, and are often much larger than the physiological blind spot; they likewise depend on the brain's filling-in mechanism to maintain a subjective sense of a "complete" visual field, carrying even greater risk than simply exposing the physiological blind spot.

Why it happens

Binocular compensation eliminates the blind-spot effect on the precondition that both eyes independently supply data for the same visual field, one making up for the other's gap. Monocular viewing removes that precondition directly — the field falling within the blind spot's position now has no eye supplying a real signal at all, leaving only perceptual filling-in still operating: a mechanism based on surrounding inference with no true/false verification. Filling-in normally maintains the illusion of "nothing feels missing" thanks to the spatial continuity natural scenes usually have; once the surrounding background is itself complex and varied, or the blind spot's position happens to need to display information different from its surroundings, filling-in can neither accurately reconstruct the true content nor actively raise an alarm saying "I have no real data here" — the sense of absence gets quietly papered over rather than being appropriately exposed.

Pathological scotomas exploit the same filling-in system mechanistically, differing in this respect: the physiological blind spot is a congenital, fixed, predictable gap that the visual system (and the person themselves) has already fully functionally adapted to over the course of development, whereas a pathological scotoma is typically a newly acquired defect, irregular in position and shape. The filling-in mechanism still tries to cover these regions using surrounding information, but because the defect is often more irregular and larger, the filled-in content can deviate more noticeably from the real scene; at the same time, patients themselves may remain subjectively unaware of their own field defect for a long time — one of the reasons diseases like glaucoma are hard to self-detect in their early stages.

Studying it

Research into the exposed monocular blind-spot effect typically builds directly on the monocular filling-in experiments described in the earlier entry in this group, comparing the detection rate for an anomalous stimulus at the blind spot's position under monocular versus binocular viewing, and quantifying the contrast effect — detection rate plummeting under monocular viewing, returning to normal under binocular viewing — as direct behavioral evidence for the binocular compensation mechanism.

Research into pathological scotomas relies mainly on clinical visual field examination (perimetry): the patient fixates with one eye while test points of varying brightness are systematically presented across the visual field, and detection thresholds are recorded point by point to construct a complete visual field sensitivity map, used to localize and quantify a scotoma's position, size, and severity — a standard tool for clinical diagnosis and disease-course monitoring in glaucoma, retinal disease, and similar conditions. The independent variable is test point position and brightness; the dependent variable is detection threshold, with defective regions showing abnormally elevated thresholds or complete undetectability.

Methodologically: a patient's reported subjective visual experience ("I feel like my vision is fine") often doesn't match the objective extent of the defect measured by visual field examination — a direct consequence of the perceptual filling-in mechanism at work. Assessing visual field status cannot rely on patient self-report alone; it needs to be based on objective visual field examination results.

Where it stops holding

• This entry covers "the defect effect surfaces," not that the effect is necessarily correctly identified by the user as 'there's a visual defect here.' Even when filling-in failure leads to a missed item or misjudgment, in many cases the user afterward still can't say specifically what went wrong, because the filling-in mechanism itself leaves no meta-information along the lines of "this part was made up."
• The severity and progression speed of pathological scotomas vary by specific disease. This entry addresses the common mechanism of the defect effect surfacing, and cannot substitute for clinical diagnosis and grading of a specific condition.
• The risk from brief monocular occlusion (a brief look through a monocular eyepiece, then returning to binocular viewing) is temporary — the risk window only exists during the actual period of monocular viewing; the binocular compensation mechanism resumes immediately once binocular viewing is restored.

Applying it

• Clearly identify whether a product or scenario involves forced or frequent monocular viewing (monocular-eyepiece devices, operations requiring one eye closed to aim or focus, user groups with one-sided vision impairment). Where it does exist, seriously assess whether the blind-spot angle could carry critical information — don't dismiss the risk on the assumption that "the user is viewing with both eyes most of the time anyway."
• For products likely to include users with visual field defects (accessibility design, older-adult user groups, health and medical apps), don't assume "the user says they can see fine" means their visual field is actually intact — critical safety-related information shouldn't rely on the user's subjectively reported visual completeness as a design assumption.
• For critical indicators in monocular-operation scenarios, refer to this group's entry on perceptual filling-in and prefer presentations that the filling-in mechanism struggles to mask — motion, flicker, abrupt boundary changes — over a static presentation highly similar to its background.
• Verification: if a product explicitly involves a monocular-operation mode, run a dedicated monocular-visibility test on the critical information presented in that mode (rather than reusing binocular test results), checking in particular whether the information falls at the angular position corresponding to the blind spot under monocular viewing.

Related

• Same group: A1.19.1 There are no photoreceptors where the optic nerve exits, creating a physiological blind spot · A1.19.2 Binocular field overlap keeps the blind spot unnoticed in daily life · A1.19.3 The brain fills in the blind spot using surrounding information, which can produce misjudgment rather than a sense of absence · A1.19.5 Critical information should not fall exactly on the blind-spot angle in monocular-use scenarios
• Nearby: A1.33 Binocular vision and eye dominance
• Search terms: monocular vision · scotoma · visual field defect · perimetry